|
Video: What is a Stock Split?
|
|
Avenue Therapeutics is a pharmaceutical company focused on the development and commercialization of therapies for the treatment of rare and neurologic diseases. Co.'s product candidates include AJ201 for the treatment of spinal and bulbar muscular atrophy, intravenous Tramadol for the treatment of post-operative acute pain, and BAER-101 for the treatment of epilepsy and panic disorders. According to our Avenue Therapeutics stock split history records, Avenue Therapeutics has had 1 split. | |
|
Avenue Therapeutics (ATXI) has 1 split in our Avenue Therapeutics stock split history database. The split for ATXI took place on September 23, 2022. This was a 1 for 15 reverse split, meaning for each 15 shares of ATXI owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.
When a company such as Avenue Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Avenue Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Avenue Therapeutics shares, starting with a $10,000 purchase of ATXI, presented on a split-history-adjusted basis factoring in the complete Avenue Therapeutics stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/29/2017 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$118.20 |
|
End price/share: |
$0.15 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.87% |
|
Average Annual Total Return: |
-62.84% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$12.52 |
|
Years: |
6.75 |
|
|
|
Date |
Ratio |
09/23/2022 | 1 for 15 |
|
|